India, Nov. 10 -- Healthcare stocks moved higher following clinical, financial and corporate updates. PepGen reported positive Phase 2 data for its muscular dystrophy candidate, Zura Bio discontinued ... Read More
India, Nov. 10 -- A measure of the public assessment of the current situation of the Japanese economy weakened more-than-expected in October, the survey data from the Cabinet Office showed on Tuesday.... Read More
India, Nov. 10 -- The major European markets finished mostly higher on Tuesday, although they trended downward throughout the day and ended on opposite sides of the unchanged line. Early in the sessi... Read More
India, Nov. 10 -- Achieve Life Sciences, now doing business as AchieveRx, The Quit Company (QUIT), reported third-quarter 2026 financial results and provided business updates, highlighting progress to... Read More
India, Nov. 10 -- GE HealthCare (GEHC) announced plans to establish the MAGNUS Neuro Alliance, a collaborative research network designed to advance neuroscience research and explore clinical applicati... Read More
India, Nov. 10 -- A study conducted by researchers at Binghamton University, State University of New York, has found that depression can change how children pay attention to facial expressions, includ... Read More
India, Nov. 10 -- Pixelworks, Inc. (PXLW) surged 19.85 percent, gaining $1.03 to $6.25, on Tuesday, after announcing a multi-year partnership and device certification agreement with Meta (META). The d... Read More
India, Nov. 10 -- PepGen Inc. (PEPG) surged 129.08 percent, gaining $3.08 to $5.47 on Tuesday. The company reported a third-quarter net loss of $19.39 million, or $0.28 per share, compared with a loss... Read More
India, Nov. 9 -- Ionis Pharmaceuticals, Inc. (IONS) reported Loss for third quarter of -$110 million The company's bottom line came in at -$110 million, or -$0.66 per share. This compares with -$129 ... Read More
India, Nov. 9 -- Foghorn Therapeutics, Inc. (FHTX), a biotechnology company developing small-molecule medicines and targeted protein degradation therapies, on Monday reported third-quarter 2026 net in... Read More